FDA approves Roche's Ventana PD-L1 assay as complementary diagnostic for atezolizumab in NSCLC Oct. 28, 2016
FDA places partial clinical hold on enrollment in durvalumab trials for head and neck cancer Oct. 28, 2016
Active Biotech grants NeoTX exclusive rights to develop and commercialize Anyara for cancer Oct. 26, 2016
Advaxis announces stage 2 results from phase II trial of axalimogene filolisbac in cervical cancer Oct. 25, 2016
RSS